Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precera Bioscience has developed and validated a platform called PrecisionCMQ™, which measures patient adherence, medical record accuracy, and blood concentrations of prescription and over-the-counter medications. Their technology has been studied in over 1,300 patients at major academic centers such as Vanderbilt University Medical Center and the Cleveland Clinic. Results show that their approach can identify discrepancies in medical records, improve detection of non-adherence or unknown medications, and flag potential drug-drug interactions[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precera Bioscience.